Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-020206
Filing Date
2025-07-23
Accepted
2025-07-23 18:52:21
Documents
1
Period of Report
2025-07-21

Document Format Files

Seq Description Document Type Size
1 form4-07232025_100717.html 4  
1 form4-07232025_100717.xml 4 6111
  Complete submission text file 0001415889-25-020206.txt   7558
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Lyssikatos Joseph P (Reporting) CIK: 0001967150 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 251144115